QRG Capital Management Inc. Has $645,000 Stock Position in Sabra Healthcare REIT, Inc. $SBRA

QRG Capital Management Inc. reduced its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 47.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 34,616 shares of the real estate investment trust’s stock after selling 31,596 shares during the period. QRG Capital Management Inc.’s holdings in Sabra Healthcare REIT were worth $645,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of SBRA. Geode Capital Management LLC boosted its stake in Sabra Healthcare REIT by 0.8% in the 2nd quarter. Geode Capital Management LLC now owns 6,613,185 shares of the real estate investment trust’s stock valued at $121,960,000 after buying an additional 55,200 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in shares of Sabra Healthcare REIT by 1.5% during the second quarter. Bank of New York Mellon Corp now owns 4,175,058 shares of the real estate investment trust’s stock valued at $76,988,000 after acquiring an additional 60,843 shares during the period. Engineers Gate Manager LP boosted its stake in shares of Sabra Healthcare REIT by 3,190.3% in the 2nd quarter. Engineers Gate Manager LP now owns 3,179,303 shares of the real estate investment trust’s stock valued at $58,626,000 after purchasing an additional 3,082,677 shares in the last quarter. Norges Bank bought a new stake in shares of Sabra Healthcare REIT in the 2nd quarter worth about $54,385,000. Finally, Balyasny Asset Management L.P. bought a new stake in shares of Sabra Healthcare REIT in the 2nd quarter worth about $49,955,000. 99.40% of the stock is owned by institutional investors and hedge funds.

Sabra Healthcare REIT Price Performance

SBRA opened at $19.31 on Thursday. The company has a debt-to-equity ratio of 0.92, a current ratio of 5.19 and a quick ratio of 5.19. The stock has a market capitalization of $4.81 billion, a P/E ratio of 26.82, a price-to-earnings-growth ratio of 1.17 and a beta of 0.67. The company’s 50 day simple moving average is $19.04 and its 200-day simple moving average is $18.69. Sabra Healthcare REIT, Inc. has a one year low of $15.60 and a one year high of $19.97.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings data on Wednesday, November 5th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.01. The firm had revenue of $190.04 million for the quarter, compared to the consensus estimate of $193.44 million. Sabra Healthcare REIT had a return on equity of 6.38% and a net margin of 23.50%.The business’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.37 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. Sell-side analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, November 28th. Investors of record on Monday, November 17th were issued a $0.30 dividend. The ex-dividend date was Monday, November 17th. This represents a $1.20 annualized dividend and a yield of 6.2%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 166.67%.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on SBRA. Wells Fargo & Company lifted their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an “overweight” rating in a report on Tuesday, November 25th. Cantor Fitzgerald assumed coverage on shares of Sabra Healthcare REIT in a research note on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 target price for the company. Weiss Ratings reissued a “buy (b)” rating on shares of Sabra Healthcare REIT in a report on Wednesday, October 8th. Jefferies Financial Group reaffirmed a “buy” rating and set a $22.00 price target on shares of Sabra Healthcare REIT in a report on Monday, December 15th. Finally, UBS Group began coverage on Sabra Healthcare REIT in a research report on Tuesday, November 18th. They issued a “neutral” rating and a $20.00 price objective for the company. Four equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $21.11.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.